Aerosol therapy in pulmonary critical care

Respiratory Care

Volumn 60, Issue 6, 2015, Pages 858-874

  Ari, Arzu ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Aerosols; Artificial airways; Drug delivery; Endotracheal tube; Mechanical ventilation; Metered dose inhalers; Nebulizers; Spacers; Tracheostomy tube

Indexed keywords

AMBROXOL; AMIKACIN; AMPHOTERICIN B; AMPICILLIN; ATROPINE; BECLOMETASONE; BICARBONATE; BROMHEXINE; BUDESONIDE; CHLOROFLUOROCARBON; DEXAMETHASONE; DORNASE ALFA; FLAVORING AGENT; FLUNISOLIDE; FLUORINATED HYDROCARBON; FLUOROCARBON; FLUTICASONE; FUROSEMIDE; HEPARIN; HYDROCORTISONE; ILOPROST; MESNA; PRESERVATIVE; PROPELLANT; PROSTACYCLIN; SALBUTAMOL; SODIUM CHLORIDE; SURFACTANT; TREPROSTINIL; UNINDEXED DRUG; AEROSOL; BRONCHODILATING AGENT;

AEROSOL; AIRWAY; ARTICLE; ARTIFICIAL VENTILATION; DENSITY; DRUG FORMULATION; GAS FLOW; HEAT; HUMAN; HUMIDITY; INHALATION SPACER; INTENSIVE CARE; INTERNAL CONSISTENCY; JET VENTILATION; MEASUREMENT PRECISION; MESH NEBULIZER; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; PEAK INSPIRATORY FLOW; RESIDUAL VOLUME; RESPIRATORY FUNCTION; TRACHEOSTOMY TUBE; VENTILATOR; DEVICES; EQUIPMENT DESIGN; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASES; PROCEDURES; RESPIRATORY CARE;

ADMINISTRATION, INHALATION; AEROSOLS; BRONCHODILATOR AGENTS; CRITICAL CARE; EQUIPMENT DESIGN; HUMANS; LUNG DISEASES; NEBULIZERS AND VAPORIZERS; RESPIRATION, ARTIFICIAL; RESPIRATORY THERAPY;

EID: 84944723449     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.03790     Document Type: Article

References (126)

1. Hess DR. Nebulizers: principles and performance. Respir Care 2000; 45(6):609-622.
2. Hess DR. Liquid nebulization: emerging technologies conference summary. Respir Care 2002;47(12):1471-1476.
3. Le Brun PP, de Boer AH, Heijerman HG, Frijlink HW. A review of the technical aspects of drug nebulization. Pharm World Sci 2000; 22(3):75-81.
4. Fink J, Ari A. Aerosol therapy in intubated patients. Expert Opin Drug Deliv 2013;10(8):1077-1093.
5. Ari A, Fink JB, Dhand R. Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv 2012;25(6):319-332.
6. Ari A, Fink JB. Factors affecting bronchodilator delivery in mechanically ventilated adults. Nurs Crit Care 2010;15(4):192-203.
7. Ari A. Aerosol therapy for mechanically ventilated patients: devices, issues, selection & technique. Clin Found 2012;14:1-12.
8. Phipps PR, Gonda I. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. Chest 1990;97(6):1327-1332.
9. Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet 2011;377(9770):1032-1045.
10. Rau JL. Design principles of liquid nebulization devices currently in use. Respir Care 2002;47(11):1257-1275; discussion 1275-1278.
11. Dhand R, Mercier E. Effective inhaled drug administration to mechanically ventilated patients. Expert Opin Drug Deliv 2007;4(1):47-61.
12. Nikander K, Turpeinen M, Wollmer P. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med 1999;12(2):47-53.
13. Steckel H, Eskandar F. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. Eur J Pharm Sci 2003;19(5):443-455.
14. Harvey CJ, O’Doherty MJ, Page CJ, Thomas SH, Nunan TO, Treacher DF. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J 1997; 10(4):905-909.
15. Ari A. Nebulizers: an evaluation of nebulizers for better clinical practice. Eurasian J Pulmonol 2014;16:1-7.
16. Dhand R. New frontiers in aerosol delivery during mechanical ventilation. Respir Care 2004;49(6):666-677.
17. Dhand R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 47(12):1406-1416, 2002; discussion 1416-1408.
18. Ari A, Atalay OT, Harwood R, Sheard MM, Aljamhan EA, Fink JB. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010;55(7):845-851.
19. Ari A, Areabi H, Fink JB. Evaluation of position of aerosol device in two different ventilator circuits during mechanical ventilation. Respir Care 2010;55(7):837-844.
20. Pitance L, Vecellio L, Leal T, Reychler G, Reychler H, Liistro G. Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. J Aerosol Med Pulm Drug Deliv 2010;23(6):389-396.
21. Rubin BK, Fink JB. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir Care 2005;50(9):1191-1200.
22. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003;56(6):600-612.
23. Newman SP. Principles of metered-dose inhaler design. Respir Care 2005;50(9):1177-1190.
24. Rau JL. The inhalation of drugs: advantages and problems. Respir Care 2005;50(3):367-382.
25. Rubin BK. Air and soul: the science and application of aerosol therapy. Respir Care 2010;55(7):911-921.
26. Hess DR. Aerosol delivery devices in the treatment of asthma. Respir Care 2008;53(6):699-723; discussion 723-725.
27. Rau JL, Dunlevy CL, Hill RL. A comparison of inline MDI actuators for delivery of a beta agonist and a corticosteroid with a mechanically-ventilated lung model. Respir Care 1998;43:705-712.
28. MacIntyre NR, Silver RM, Miller CW, Schuler F, Coleman RE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985;13(2):81-84.
29. Fuller HD, Dolovich MB, Posmituck G, Pack WW, Newhouse MT. Pressurized aerosol versus jet aerosol delivery to mechanically ven- tilated patients. Comparison of dose to the lungs. Am Rev Respir Dis 1990;141(2):440-444.
30. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997;156(1):3-10.
31. Fink J, Dhand R, Duarte A, Jenne J, Tobin M. Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An invitro model. Am J Respir Crit Care Med 1996;154(2):382-387.
32. Fuller HD, Dolovich MB, Chambers C, Newhouse MT. Aerosol delivery during mechanical ventilation: a predictive in-vitro lung model. J Aerosol Med 1992;5(4):251-259.
33. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ. Reconciling in vitro and in vivo measurements of aerosol delivery from a metered- dose inhaler during mechanical ventilation and defining efficiency- enhancing factors. Am J Respir Crit Care Med 1999;159(1): 63-68.
34. Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 1995;152(4 Pt 1):1391- 1394.
35. Rau JL, Harwood RJ, Groff JL. Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults: an invitro study. Chest 1992;102(3):924-930.
36. Morén F, Anderson J. Fraction of dose exhaled after administration of pressurized inhalation aerosols. Int J Pharm 1980;6(3-4):295-300.
37. Goode ML, Fink JB, Dhand R, Tobin MJ. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001;163(1):109-114.
38. O’Doherty MJ, Thomas SH, Page CJ, Treacher DF, Nunan TO. Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis 1992;146(2):383-388.
39. Thomas SH, O’Doherty MJ, Page CJ, Treacher DF, Nunan TO. Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am Rev Resp Dis 1993;148(4):872-877.
40. Thomas SH, O’Doherty MJ, Fidler HM, Page CJ, Treacher DF, Nunan TO. Pulmonary deposition of a nebulised aerosol during mechanical ventilation. Thorax 1993;48(2):154-159.
41. Hess DR, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996;110(2):498-505.
42. Harvey CJ, O’Doherty MJ, Page CJ, Thomas SH, Nunan TO, Treacher DF. Effect of a spacer on pulmonary aerosol deposition from a jet nebulizer during mechanical ventilation. Thorax 1995; 50(1):50-53.
43. Newman SP. How well do in vitro particle size measurements predict drug delivery in vivo? J Aerosol Med 1998;11(Suppl 1): S97-104.
44. Dhand R, Sohal H. Pulmonary drug delivery system for inhalation therapy in mechanically ventilated patients. Expert Rev Med Devices 2008;5(1):9-18.
45. Waldrep JC, Berlinski A, Dhand R. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer. J Aerosol Med 2007;20(3):310-319.
46. Van Dyke RE, Nikander K. Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb adaptive aerosol delivery systems: an in vitro study. Respir Care 2007;52(2):184-190.
47. Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharm Sci 1969;58(4):484-486.
48. Kim CS, Trujillo D, Sackner MA. Size aspects of metered-dose inhaler aerosols. Am Rev Respir Dis 1985;132(1):137-142.
49. Ehrmann S, Roche-Campo F, Sferrazza Papa GF, Isabey D, Brochard L, Apiou-Sbirlea G. Aerosol therapy during mechanical ventilation: an international survey. Intensive Care Med 2013;39(6): 1048-1056.
50. MacNeish CF, Meisner D, Thibert R, Kelemen S, Vadas EB, Coates AL. A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) respirator solution. Chest 1997;111(1):204-208.
51. Berlinski A, Waldrep JC. Nebulized drug admixtures: effect on aerosol characteristics and albuterol output. J Aerosol Med 2006; 19(4):484-490.
52. Coates AL, MacNeish CF, Meisner D, Kelemen S, Thibert R, Mac- Donald J, Vadas E. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols. Chest 1997;111(5):1206-1212.
53. Flament MP, Leterme P, Burnouf T, Gayot A. Influence of formulation on jet nebulisation quality of _1 protease inhibitor. Int J Pharm 1999;178(1):101-109.
54. Lee TY, Chen CM, Lee CN, Chiang YC, Chen HY. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Am J Health Syst Pharm 2005;62(8): 828-833.
55. Joseph JC. Compatibility of nebulizer solution admixtures. Ann Pharmacother 1997;31(4):487-489.
56. Kamin W, Schwabe A, Krämer I. Inhalation solutions: which ones are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers. J Cyst Fibros 2006;5(4):205-213.
57. McKenzie JE, Cruz-Rivera M. Compatibility of budesonide inhalation suspension with four nebulizing solutions. Ann Pharmacother 2004;38(6):967-972.
58. Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers. How reliable are they? Chest 1992;101(2):316-319.
59. Loffert DT, Ikle D, Nelson HS. A comparison of commercial jet nebulizers. Chest 1994;106(6):1788-1792.
60. Terzano C, Petroianni A, Parola D, Ricci A. Compressor/nebulizer differences in the nebulization of corticosteroids. The CODE study (Corticosteroids and Devices Efficiency). Eur Rev Med Pharmacol Sci 2007;11(4):225-237.
61. Waldrep JC, Keyhani K, Black M, Knight V. Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 1994;105(1):106-110.
62. Craven DE, Goularte TA, Make BJ. Contaminated condensate in mechanical ventilator circuits: a risk factor for nosocomial pneumonia. Am Rev Respir Dis 1984;129(4):625-628.
63. Beaty CD, Ritz RH, Benson MS. Continuous in-line nebulizers complicate pressure support ventilation. Chest 1989;96(6):1360- 1363.
64. Phillips GD, Millard FJ. The therapeutic use of ultrasonic nebulizers in acute asthma. Respir Med 1994;88(5):387-389.
65. Dhand R, Guntur VP. How best to deliver aerosol medications to mechanically ventilated patients. Clin Chest Med 2008;29(2):277-296.
66. Dhand R. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliv 2008;21(1):45-60.
67. Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv 2008;5(2):114-119.
68. Hurley PK, Smye SW, Cunliffe H. Assessment of antibiotic aerosol generation using commercial jet nebulizers. J Aerosol Med 1994; 7(3):217-228.
69. Dhand R. Aerosol therapy during mechanical ventilation: getting ready for prime time. Am J Respir Crit Care Med 2003;168(10): 1148-1149.
70. Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 2003;168(10):1205-1209.
71. Hughes J, Saez J. Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care 1987; 32(12):1131-1135.
72. Sidler-Moix AL, Dolci U, Berger-Gryllaki M, Pannatier A, Cotting J, Di Paolo ER. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic and mesh nebulizers. Pediatr Crit Care Med 2013;14(2):e98-e102.
73. Wan GH, Lin HL, Fink JB, Chen YH, Wang WJ, Chiu YC, et al. In vitro evaluation of aerosol delivery by different nebulization modes in pediatric and mechanical ventilator modes. Respir Care 2014;59(10):1494-1500.
74. Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care 2013;58(7):1124-1133.
75. Moraine JJ, Truflandier K, Vandenbergen N, Berre´ J, Mélot C, Vincent JL. Placement of the nebulizer before the humidifier during mechanical ventilation: Effect on aerosol delivery. Heart Lung 2009; 38(5):435-439.
76. Fink J. Metered-dose inhalers, dry powder inhalers and transitions. Respir Care 2000;45(6):623-635.
77. Everard ML, Devadason SG, Summers QA, Le Souëf PN. Factors affecting total and “respirable” dose delivered by a salbutamol metered dose inhaler. Thorax 1995;50(7):746-749.
78. O’Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993;48(6):603-606.
79. Barry PW, O’Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol 1995;40(1):76-78.
80. Clark DJ, Lipworth BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax 1996;51(10):981-984.
81. Rau JL, Zhu Y. Reservoir design and dose availability with longterm metered dose inhaler corticosteroid use. J Aerosol Med 1998; 11(1):15-26.
82. Bishop MJ, Larson RP, Buschman DL. Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/ adapter used. Anesthesiology 1990;73(6):1263-1265.
83. Williams RO 3rd, Patel AM, Barron MK, Rogers TL. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI. Drug Dev Ind Pharm 2001; 27(5):401-412.
84. Fuller HD, Dolovich MB, Turpie FH, Newhouse MT. Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients. A study comparing four different actuator devices. Chest 1994;105(1):214-218.
85. Dhand R, Duarte AG, Jubran A, Jenne JW, Fink JB, Fahey PJ, Tobin MJ. Dose response to bronchodilator delivered by metereddose inhaler in ventilator supported patients. Am J Respir Crit Care Med 1996;154(2):388-393.
86. Dhand R, Tobin MJ. Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients. Eur Respir J 1996; 9(3):585-595.
87. O’Riordan TG, Palmer LB, Smaldone GC. Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 1994;149(1):214-219.
88. Guerin C, Fassier T, Bayle F, Lemasson S, Richard JC. Inhaled bronchodilator administration during mechanical ventilation: how to optimize it and for which clinical benefit? J Aerosol Med Pulm Drug Deliv 2008;21(1):85-96.
89. Hess DR, Dillman C, Kacmarek RM. In vitro evaluation of aerosol bronchodilator delivery during mechanical ventilation: pressurecontrol vs. volume control ventilation. Intensive Care Med 2003; 29(7):1145-1150.
90. Andersen JB, Klausen NO. A new mode of administration of nebulized bronchodilator in severe bronchospasm. Eur J Respir Dis Suppl 1982;119:97-100.
91. Fink JB, Tobin MJ, Dhand R. Bronchodilator therapy in mechanically ventilated patients. Respir Care 1999;44(1):53-69.
92. Crogan SJ, Bishop MJ. Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology 1989;70(6):1008-1010.
93. Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metereddose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy 1994;14(2):210-214.
94. Ryan SN, Rankin N, Meyer E, Williams R. Energy balance in the intubated human airway is an indicator of optimal gas conditioning. Crit Care Med 2002;30(2):355-361.
95. Schulze A. Respiratory gas conditioning in infants with an artificial airway. Semin Neonatol 2002;7(5):369-377.
96. Lange CF, Finlay WH. Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation. Am J Respir Crit Care Med 2000;161(5):1614-1618.
97. Lin HL, Fink JB, Zhou Y, Cheng YS. Influence of moisture accumulation in inline spacer on delivery of aerosol using metered-dose inhaler during mechanical ventilation. Respir Care 2009;54(10):1336-1341.
98. Bowers W. Effects of heat and moisture exchangers designed to allow aerosol delivery on aerosol deposition in simulated mechanically ventilated adults. Atlanta, GA: Georgia State University; 2010.
99. Svartengren M, Anderson M, Philipson K, Camner P. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res 1989;15(4):575-585.
100. Ari A, Fink J. Aerosol drug delivery administration with heliumoxygen (heliox) mixtures: an overview. Curr Respir Med Rev 2010; 6(2):80-85.
101. Duarte AG. Inhaled bronchodilator administration during mechanical ventilation. Respir Care 2004;49(6):623-634.
102. Tassaux D, Jolliet P, Thouret JM, Roeseler J, Dorne R, Chevrolet JC. Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures. Am J Respir Crit Care Med 1999; 160(1):22-32.
103. Takaya T, Takeyama K, Takiguchi M. The efficiency of β2-agonist delivery through tracheal tubes with the metered-dose inhaler: an in vitro study. J Anesth 2002;16(4):284-288.
104. Ahrens RC, Ries RA, Popendorf W, Wiese JA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol 1986;2(1):19-26.
105. O’Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation.AmRev Respir Dis 1992;145(5): 1117-1122.
106. Piccuito CM, Hess DR. Albuterol delivery via tracheostomy tube. Respir Care 2005;50(8):1071-1076.
107. Ari A, Harwood RJ, Sheard MM, Fink JB. An in vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care 2012;57(7):1066-1070.
108. Berlinski A. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy. Respir Care 2013; 58(12):2076-2086.
109. Berlinski A, Chavez A. Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatr Pulmonol 2013;48(10):1026-1034.
110. Mirza S, Hopkinson L, Malik TH, Willatt DJ. The use of inhalers in patients with tracheal stomas or tracheostomy tubes. J Laryngol Otol 1999;113(8):762-764.
111. Nakhla V. A homemade modification of a spacer device for delivery of bronchodilator or steroid therapy in patients with tracheostomies. J Laryngol Otol 1997;111(4):363-365.
112. Parkes SN, Bersten AD. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Thorax 1997;52(2):171-175.
113. MacIntyre N. Aerosol delivery through an artificial airway. Respir Care 2002;47(11):1279-1285; discussion 1285-1289.
114. Dhand R. Special problems in aerosol delivery: artificial airways. Respir Care 2000;45(6):636-645.
115. Pitance L, Vecellio L, Delval G, Reychler G, Reychler H, Liistro G. Aerosol delivery through tracheostomy tubes: an in vitro study. J Aerosol Med Pulm Drug Deliv 2013;26(2):76-83.
116. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidencebased guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1): 335-371.
117. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011;37(6):1308-1331.
118. Marik P, Hogan J, Krikorian J. A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients. Chest 1999;115(6):1653-1657.
119. Ely EW, Baker AM, Evans GW, Haponik EF. The distribution of costs of care in mechanically ventilated patients with chronic obstructive pulmonary disease. Crit Care Med 2000;28(2):408-413.
120. Dhand R. Inhalation therapy in invasive and noninvasive mechanical ventilation. Curr Opin Crit Care 2007;13(1):27-38.
121. Dhand R. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients. Respir Care 2005;50(10):1331-1334; discussion 1344-1345.
122. Duarte AG, Momii K, Bidani A. Bronchodilator therapy with metered dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response. Respir Care 2000;45(7):817-823.
123. Chang LH, Honiden S, Haithcock JA, Das AM, Short KA, Nierman DM, Carson SS. Utilization of bronchodilators in ventilated patients without obstructive airways disease. Respir Care 2007;52(2): 154-158.
124. Craven DE, Lichtenberg DA, Goularte TA, Make BJ, McCabe WR. Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med 1984;77(5):834-838.
125. Hamill RJ, Houston ED, Georghiou PR, Wright CE, Koza MA, Cadle RM, et al. An outbreak of Burkholderia cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122(10):762-766.
126. Hamill RJ, Houston ED, Georghiou PR, Wright CE, Koza MA, Cadle RM, et al. Respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995; 122(10):762-766.